Else Nutrn (OTCMKTS:BABYF – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.11) earnings per share (EPS) for the quarter, Zacks reports. The firm had revenue of $0.74 million during the quarter.
Else Nutrn Stock Down 38.4%
OTCMKTS:BABYF opened at $0.11 on Wednesday. The business’s 50-day simple moving average is $0.09 and its two-hundred day simple moving average is $0.05. Else Nutrn has a 52 week low of $0.01 and a 52 week high of $0.37. The stock has a market cap of $833,457.00, a PE ratio of -0.03 and a beta of 0.98.
Else Nutrn Company Profile
Else Nutrition Holdings Inc is a plant-based infant and toddler nutrition company that develops dairy-free, soy-free and gluten-free formula powders under its flagship ELSE brand. The company’s core product line includes Stage 1 infant formula and Stage 3 toddler nutrition powders formulated with a proprietary blend of almond, buckwheat and tapioca ingredients designed to mimic the nutritional profile of traditional milk‐based formulas. These products are non-GMO and aim to address food sensitivities and allergen concerns in early childhood nutrition.
Founded in 2019 and headquartered in Tel Aviv, Israel, Else Nutrition began commercial sales in 2021 with initial distribution in Canada and Israel.
Further Reading
- Five stocks we like better than Else Nutrn
- 2 “Cheap for a Reason” Airline Stocks That May Be Worth the Risk
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
Receive News & Ratings for Else Nutrn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Else Nutrn and related companies with MarketBeat.com's FREE daily email newsletter.
-limited-logo-1200x675.png){kind=logo}
